Abdominal obesity increases overnight cortisol excretion

Journal of Endocrinological Investigation

Volumn 22, Issue 6, 1999, Pages 465-471

  Duclos, M ^a,c   Corcuff, J B ^b   Etcheverry, N ^a   Rashedi, M ^a   Tabarin, A ^a   Roger, P ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Service d'Endocrinologie   (France)

Author keywords

Abdominal obesity; Dexamethasone suppressing test; Saliva cortisol; Urinary cortisol

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HYDROCORTISONE; TRIACYLGLYCEROL;

ABDOMEN; ADOLESCENT; ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; OBESITY; SALIVA LEVEL; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032820237     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343591     Document Type: Article

References (32)

1. Strain G.W., Zumoff B., Strain J.J., Levin J., Fukushima D.K. Cortisol production in obesity. Metabolism 1980, 29: 980.
2. Pasquali R., Cantobelli S., Casimirri F., Capelli M., Bortoluzzi L., Flamia R., Labate A.M.M., Barbara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab. 1993, 77: 341.
3. Weaver J.U., Kopelman P.G., McLoughlin L., Forsling M.L., Grossman A. Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, β-lipotrophin and cortisol responses to insulin-induced hypoglycaemia. Clin. Endocrinol. (Oxf.) 1993, 39: 345.
4. Björntrop P. Metabolic implications of body fat distribution. Diabetes Care 1991, 14: 1132.
5. Björntrop P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1991, 13: 795.
6. Boushaki F.Z., Rasio E., Serri O. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine. Clin. Endocrinol (Oxf.) 1997, 46: 461.
7. Mårin P., Darin N., Amemiya T., Andersson B., Jern S., Björntrop P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992, 41: 882.
8. Hautanen A., Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J. Intern. Med. 1993, 234: 461.
9. Pasquali R., Biscotti D., Spinucci G., Vicennati V., Genazzani A.D., Sgarbi L., Casimirri F. Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution. Clin. Endocrinol. (Oxf.) 1998, 48: 603.
10. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr. Rev. 1990, 11: 80.
11. Umeda T., Hiramatsu R., Iwaoka T., Shimada T., Miura F., Sato T. Use of saliva for monitoring unbound free cortisol levels in serum. Clin. Chim. Acta 1981, 110: 245.
12. Corcuff J.-B., Tabarin A., Rashedi M., Duclos M., Roger P., Ducassou D. Overnight urinary free cortisol determination: a screening test for Cushing's syndrome. Clin. Endocrinol. (Oxf.) 1998, 48: 503.
13. Migeon C.J., Green O.C., Eekert J.P. Study of adrenocortical function in obesity. Metabolism 1963, 12: 718.
14. Radloff L.S. The CES-D scale: a self report depression scale for research in the general population. Appl. Psych. Meas. 1997, 1: 385.
15. World Health Organization. Measuring obesity-classification and description of anthropometric data Report on a WHO consultation of the epidemiology of obesity. Copenhagen, Denmark, Nutrition Unit, WHO, EUR/HFA, 1989.
16. Lemieux S., Prudhomme D., Bouchard C., Tremblay A., Despres J.P. Single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose-tissue. Am. J. Clin. Nutr. 1996, 64: 685.
17. Taylor R.W., Keil D., Gold E.J., Williams S.M., Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am. J. Clin. Nutr. 1998, 67: 44.
18. Crapo L. Cushing's syndrome: a review of diagnostic tests. Metabolism 1979, 28: 955.
19. Cronin C., Igoe D., Duffy M.J., Cunningham S.K.K., McKenna T.J. The morning dexamethasone test is a worthwhile screening procedure. Clin. Endocrinol. (Oxf.) 1990, 33: 27.
20. Edelstein C.K., Roybyrne P., Fawzy F.I., Dornfeld L. Effects of weight-loss on the dexamethasone suppression test. Am. J. Psych. 1983, 140: 338.
21. Yanovski S.Z., Yanovski J.A., Gwirtsman H.E., Bernat A., Gold P.W., Chrousos G.P. Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss. J. Clin. Endocrinol. Metab. 1993, 76: 675.
22. Ljung T., Andersson B., Bengtsson B.A., Björntrop P., Mårin P. Inhibition of cortisol secretion by dexamethasone in relation to body-fat distribution - a dose-response study. Obesity Res. 1996, 4: 277.
23. Huizenga N.A.T.M., Koper J.W., De Lange P., Pols H.A.P., Stolk R.P., Grobbee D.E., De Jong F.H., Lamberts S.W.J. Interperson variability but intraperson stability of baseline cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J. Clin. Endocrinol. Metab. 1998, 83: 47.
24. Bujalska I.J., Kumar S., Stewart P.M. Does central obesity reflect «Cushing's disease of the omentum»? Lancet 1997, 349: 1210.
25. Rissanen P., Hamalainen P., Vanninen E., Tenhunen-Eskelinen M., Uusitupa M. Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women. Int. J. Obes. Relat. Metab. Disord. 1997, 21: 367.
26. Hauner H., Entenmann G., Wabitsch M., Gaillard D., Ailhaud G., Negrel R., Pfeiffer E.F. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Invest. 1989, 84: 1663.
27. Buemann B., Vohl M.C., Chagnon M., Chagnon Y.C., Gagnon J., Perusse L., Dionne F., Despres J.P., Tremblay A., Nadeau A., Bouchard C. Abdominal visceral fat is associated with a Bcll restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obesity Res. 1995, 5: 186.
28. Hautanen A., Räikkönen K., Adlercreutz H. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinemia and dyslipidemia in normotensive males. J. Intern. Med. 1997, 241: 451.
29. Korbonits M., Trainer P.J., Nelson M.L., Howse I., Kopelman P.G., Besser G.M., Grossman A.B., Svec F. Differential stimulation of cortisol and dehydro-epiandrosterone levels by food in obese and normal subjects: relation to body fat distribution. Clin. Endocrinol. (Oxf.) 1996, 45: 699.
30. Rosmond R., Dallman M.F., Björntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 1998, 83: 1853.
31. Wang C.N., McLeod R.S., Yao Z., Brindley D.N. Effects of dexamethasone on the synthesis, degradation and secretion of apolipoprotein B in cultured rat hepatocytes. Arterioscler. Thromb. Vasc. Biol. 1995, 15: 1481.
32. Reaven G. Banting lecture: role of insulin resistance in human disease. Diabetes 1988, 37: 1595.